Search Results
12 items found for "Thue W Schwartz"
- VAMP2: a crucial player in the delivery of MOR to the synapse
., W. Ko, Z.Y. Weinberg, and M.A. Puthenveedu. 2021. Wickner, W., and R. Schekman. 2008. Membrane fusion. Nat. Struct. Mol. Biol. 15:658–664.
- Nanobodies: New Dimensions in GPCR Signaling Research
., Weis, W. I., & Kobilka, B. K. (2011). C., Gmeiner, P., Steyaert, J., Weis, W. I., Garcia, K. C., Wess, J., & Kobilka, B. K. (2013).
- Do You Believe AI Could Accelerate Drug Discovery?
Nature 630, 493–500 (2024). https://doi.org/10.1038/s41586-024-07487-w
- Ode to GPCRs
Earl W. Earl W. Earl W. Sir James W. Sir James W.
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Thus, this finding raises the possibility that GPCR priming might result not only from intricate receptor-G Stallaert, W., et al., Purinergic Receptor Transactivation by the β(2)-Adrenergic Receptor Increases
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Guo, W., et al., Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface
- From DNA day to GPCR genomics
W., & Skiniotis, G. (2023).
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
., Coyote-Maestas, W., & Aashish Manglik. (2024).
- 📰 GPCR Weekly News, March 25 to March 31, 2024
This week's highlight includes congrats to: Junyi Liang, Niña Caculitan, and Adam W Smith for their research
- Odorant receptors – a bit of smell for drug discovery
For example, OR4M1 was proposed to interfere with aberrant tau hyperphosphorylation (Zhao W. et. al 2013
- Chemokine receptor-targeted drug discovery: progress and challenges
development of biased ligands, which promote the engagement of the receptor with a certain effector, thus therapeutic applications are situated in the area of chronic inflammatory disease (Proudfoot, Power, and Schwarz
- Decoding β-Arrestins: from Structure to function
Thus, exploring large-scale protein-protein interaction datasets could shed light on connections between their imbalance is linked to pathological conditions, including cancer (Gros, R. et al. 2000, Sun, W.